Safety and feasibility of S-1 after capecitabine-induced toxicity in the adjuvant treatment of colon cancer patients: A population-based real-world study.-论文-万方医学网

第一作者： Avin,Ghedri

第一单位： Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands. Electronic address: a.ghedri-2@umcutrecht.nl.

作者： Avin,Ghedri ^[1] ; Frederieke H,van der Baan ^[2] ; Johannes M M B,Otten ^[3] ; Marloes A G,Elferink ^[4] ; Frederiek,Terheggen ^[5] ; Mathijs P,Hendriks ^[6] ; Anne M,May ^[7] ; Miriam,Koopman ^[2] ; Cornelis J A,Punt ^[8] ; Johannes J M,Kwakman ^[2] ; PLCRC study group

作者单位： Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands. Electronic address: a.ghedri-2@umcutrecht.nl. ^[1] Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands. ^[2] Department of Medical Oncology, Meander Medical Center, Maatweg 3, Amersfoort 3813 TZ, the Netherlands. ^[3] Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), P.O. Box 19079, Utrecht 3501 DB, the Netherlands. ^[4] Department of Medical Oncology, Bravis Hospital, Boerhaavelaan 25, Roosendaal 4708 AE, the Netherlands. ^[5] Department of Medical Oncology, Northwest Clinics, Wilhelminalaan 12, Alkmaar 1815 JD, the Netherlands. ^[6] Department of Epidemiology & Health Economics, Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands; Department of Psychosocial Research and Epidemiology,Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands. ^[7] Department of Epidemiology & Health Economics, Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands. ^[8]

医学主题词回顾性研究(Retrospective Studies);前瞻性研究(Prospective Studies);人类(Humans);男(雄)性(Male);女(雌)性(Female);成年人(Adult);中年人(Middle Aged);老年人(Aged);可行性研究(Feasibility Studies);结肠肿瘤(Colonic Neoplasms);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);化学疗法, 辅助(Chemotherapy, Adjuvant);药物替代(Drug Substitution);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);治疗结果(Treatment Outcome);心脏病(Heart Diseases);复方合剂(Drug Combinations);喃氟啶(Tegafur);氧嗪酸(Oxonic Acid);吡啶类(Pyridines)

DOI 10.1016/j.ejca.2026.116588

PMID 41724114

发布时间 2026-03-18

检索历史清除

Safety and feasibility of S-1 after capecitabine-induced toxicity in the adjuvant treatment of colon cancer patients: A population-based real-world study.

European journal of cancer (Oxford, England

相似文献

同项目论文

European journal of cancer (Oxford, England

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and feasibility of S-1 after capecitabine-induced toxicity in the adjuvant treatment of colon cancer patients: A population-based real-world study.

European journal of cancer (Oxford, England

相似文献

同项目论文

European journal of cancer (Oxford, England

相关期刊

检索历史清除